Joan's Legacy: Uniting Against Lung Cancer
27 Union Square West, Suite 304, New York, NY 10003 • ph: 212.627.5500 • fax: 212.627.7594
 
 

 

William W. Young, Jr., Ph.D., University of Louisville Research Foundation: MUC1 Splice Variants and Estrogen Receptors in Lung Adenocarcinoma

This grant is being fully funded by the Thomas G. Labrecque Foundation, through the Joan’s Legacy Grant Program.

Lung cancer is the leading cause of cancer deaths for men and women. The higher frequency of lung adenocarcinoma in women than in men, in both smokers and non-smokers, suggests that gender-dependent factors are part of the causes of lung cancer. The long-term goal of the proposed research is to determine the mechanism(s) responsible for this gender bias for lung adenocarcinoma in women.

The action of female hormones, estrogens, is mediated by proteins called estrogen receptors (ER) inside cells. Mucins are large proteins found on cell surfaces that sense the environment outside the cell and transmit signals about the environment to the inside of the cell. Our proposal is based on three findings. Recently one of these mucins, called MUC1, was shown to bind to ER and to increase the activity of ER. Second, a report published this year by our collaborators found that although lung cancer cells from men and women both contain the same amount of ER, only in lung cancer cells from women does exposure to estrogen stimulate the cells to grow. Because uncontrolled growth is a characteristic of cancer cells, these latter results suggested that ER may be involved in the gender bias for lung adenocarcinoma. Third, our laboratory has found that there is a difference in the frequency of two forms of MUC1 in lung carcinoma cells from women as compared to cells from men.

We propose that those different frequencies of MUC1 forms, if confirmed by testing a larger number of tumors, may be useful for predicting which persons may be more or less susceptible to developing lung adenocarcinoma. We also propose to characterize the relationship between ER and MUC1 in order to determine if the interaction of these two key proteins may be involved in the gender bias for lung adenocarcinoma in women.

 
 
Joan's Legacy: Uniting Against Lung Cancer is a 501(c)(3) tax-exempt organization.